“Description of the 3 Tranquillo Phase 3 Clinical Program Study Designs to Assess Ritlecitinib Treatment in Adults and Adolescents With Nonsegmental Vitiligo”. 2025. SKIN The Journal of Cutaneous Medicine 9 (6): s714. https://doi.org/10.25251/rm8etw25.